The table below shows AbbVie Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Revenue
$15.00B
$16.62B
$15.78B
$15.42B
$13.34B
$15.10B
Cost of revenue
$4.22B
-
$5.30B
$4.35B
$4.00B
-
Gross profit
-
$12.07B
-
-
-
$10.71B
R&D
-
-
-
-
-
-
SG&A
ABBV annual revenue (10-K history)
AbbVie Inc. reported annual revenue of $61.16B for fiscal year 2025. That is up 8.6% from $56.33B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $25.64B (FY 2016) to $61.16B. Figures come from the company's audited annual reports as filed with the SEC.
